Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
Haojie Zhang, Yuying Wang, Chi Chen, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 13, pp. 1593-1601
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. 2691-2700
Open Access | Times Cited: 184
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
Grace En Hui Lim, Ansel Shao Pin Tang, Cheng Han Ng, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 21, Iss. 3, pp. 619-629.e7
Open Access | Times Cited: 180
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 140
MAFLD: a multisystem disease
Rosaria Maria Pipitone, Carlo Ciccioli, Giuseppe Infantino, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 97
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Xiaodong Zhou, Jingjing Cai, Giovanni Targher, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 773-791
Open Access | Times Cited: 86
Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
Ting Tian, Jingxian Zhang, Wei Xie, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4505-4505
Open Access | Times Cited: 68
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Dan‐Qin Sun, Giovanni Targher, Christopher D. Byrne, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 3, pp. 386-403
Open Access | Times Cited: 53
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 29
Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups
Ibrahim Ayada, Laurens A. van Kleef, Louise J. M. Alferink, et al.
Liver International (2021) Vol. 42, Iss. 2, pp. 277-287
Closed Access | Times Cited: 89
Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota
Heng Wan, Yuying Wang, Haojie Zhang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 232, pp. 113257-113257
Open Access | Times Cited: 53
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
Jingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Endocrine Practice (2022) Vol. 28, Iss. 7, pp. 667-672
Closed Access | Times Cited: 52
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
Huapeng Lin, Xinrong Zhang, Guanlin Li, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 46
MAFLD and CKD: An Updated Narrative Review
Alessandro Mantovani, Rosa Lombardi, Filippo Cattazzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7007-7007
Open Access | Times Cited: 34
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
Karl Vaz, Daniel Clayton‐Chubb, Ammar Majeed, et al.
Hepatology International (2023) Vol. 17, Iss. 5, pp. 1082-1097
Open Access | Times Cited: 19
The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis
Nenny Agustanti, Nanny Natalia Mulyani Soetedjo, Fachreza Aryo Damara, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 5, pp. 102780-102780
Closed Access | Times Cited: 17
Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
Shaojie Duan, Deshuang Yang, Hui Xia, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS)
John A. D’Elia, Larry A. Weinrauch
Biomedicines (2024) Vol. 12, Iss. 5, pp. 978-978
Open Access | Times Cited: 4
Association between dietary zinc intake amount and prevalence of osteoporosis in middle-aged and elderly individuals: a cross-sectional study
Xiang Zhang, Jing Zhang, Lei Shen, et al.
Irish Journal of Medical Science (1971 -) (2025)
Closed Access
Cardiovascular Manifestations of Patients with Non-Alcoholic Fatty Liver Disease
Vlad Pădureanu, Mircea-Cătălin Forțofoiu, Mircea Pîrșcoveanu, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 149-149
Open Access
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis
Jianghua Zhou, Dan‐Qin Sun, Giovanni Targher, et al.
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100005-e100005
Open Access | Times Cited: 11
Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review
Yi-Fang Li, Xuetao Wang, Jun Zhang, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 23, Iss. 3, pp. 387-400
Closed Access | Times Cited: 26
Prevalence of non-alcoholic fat disease liver in Russian Federation: meta-analysis
И. В. Маев, Д. Н. Андреев, Yu. A. Kucheryavyy
Consilium Medicum (2023) Vol. 25, Iss. 5, pp. 313-319
Open Access | Times Cited: 10
Associations of Sugar-Sweetened Beverages, Artificially Sweetened Beverages, and Pure Fruit Juice With Nonalcoholic Fatty Liver Disease: Cross-sectional and Longitudinal Study
Ying Sun, Bowei Yu, Yuying Wang, et al.
Endocrine Practice (2023) Vol. 29, Iss. 9, pp. 735-742
Closed Access | Times Cited: 10
Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trial
Alireza Ramandi, Jacob George, Shahin Merat, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 882-888
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top